Characteristics, Growth Rate and Diameter at Rupture of Abdominal Aortic Aneurysms Without an Intraluminal Thrombus
AORTA · 01.10.2023 · 11 (05) · 1-18
DOI: 10.1055/s-0044-1787944 ↗Kurz gefasst
Fachartikel in der Zeitschrift AORTA, erschienen am 01.10.2023. Verfasst von Moritz Lindquist Liljeqvist und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Scarce data is available on the characteristics of the small share of AAAs that do not develop an ILT.
Methods
Two retrospective samples were studied. One group was treated electively (n=234, growth rates available for n=163 and growth after a baseline computed tomography [CT] available for n=129) and one group was treated for rupture (n=133). Growth rates of the electively treated AAAs were calculated based on all available measurements preceding surgery. Maximal ILT thickness was measured perpendicularly to the aneurysms’ centerline and was defined as absent if no intraluminal contrast deficit was detected, minimal if the ILT thickness was
Zitieren
APA
Liljeqvist, M. L., Joshi, A., Siika, A., Bogdanovic, M., Stoisavljevic, S., Hultgren, R., & Roy, J. (2023). Characteristics, Growth Rate and Diameter at Rupture of Abdominal Aortic Aneurysms Without an Intraluminal Thrombus. AORTA, 11(05), 1-18. https://doi.org/10.1055/s-0044-1787944
Vancouver
Liljeqvist ML, Joshi A, Siika A, Bogdanovic M, Stoisavljevic S, Hultgren R, et al. Characteristics, Growth Rate and Diameter at Rupture of Abdominal Aortic Aneurysms Without an Intraluminal Thrombus. AORTA. 2023;11(05):1-18. doi:10.1055/s-0044-1787944
BibTeX
@article{Liljeqvist2023,
author = {Liljeqvist, Moritz Lindquist and Joshi, Asta and Siika, Antti and Bogdanovic, Marko and Stoisavljevic, Stefan and Hultgren, Rebecka and Roy, Joy},
title = {Characteristics, Growth Rate and Diameter at Rupture of Abdominal Aortic Aneurysms Without an Intraluminal Thrombus},
journal = {AORTA},
year = {2023},
volume = {11},
number = {05},
pages = {1--18},
doi = {10.1055/s-0044-1787944}
}
EUVIMED